This is a federal contract award from the National Institute of Child Health and Human Development (NICHD), a civilian agency, to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The contract, identified as HHSN275201300003I/HHSN27500004, is for the "Contraceptive Clinical Trial Network - Female Sites - Evaluation of LARCs Study". It is a cost-type delivery order contract with a ceiling value of $355,572.17 and a completion date of September 30, 2022. The contract does not have a set-aside designation. The University of Colorado-Denver is the prime contractor and is a major public research university that receives substantial federal funding through contracts and grants to support its research, education, and public service missions. This contract is likely part of NICHD's broader research and clinical studies program focused on contraceptive development and evaluation.